MitoAction in the News

FDA Approval of KYGEVVI Marks a Defining Moment for Mitochondrial Disease Community and Families Affected by TK2d

FOR IMMEDIATE RELEASE

Contact:Emily GrandahlMarketing Coordinator, MitoActionemily@mitoaction.org(888) …